Finance Home - My Yahoo - Yahoo! - Help

Thursday, December 24, 2009, 9:53PM ET - U.S. Markets closed early today. Dow  0.51% Nasdaq  0.71%

Urigen Pharmaceuticals, Inc. (URGP.OB)

At 11:08AM ET: 0.115   0.003 (2.54%)

MORE ON URGP.OB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Company Events Get Company Events for:
UPCOMING EVENTS   Date Event Reminder No Upcoming Events RECENT EVENTS   Date Event 21-Dec-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure 7-Dec-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 16-Nov-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 29-Oct-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure 28-Oct-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities 24-Sep-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report 26-Aug-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and 20-Aug-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exh 24-Jul-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 12-Jun-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers 15-May-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 29-Apr-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and Exh 17-Feb-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report 15-Jan-09 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Fi 29-Dec-08 URIGEN PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure
Add to Portfolio     Set Alert     Email to a Friend Get Company Events for Another Symbol: Symbol Lookup • Splits Calendar • Mergers & Acquisitions Calendar